Clinical efficacy of herbal compress therapy with modified Taohong Siwu Decoction in patients with venous leg ulcers with qi deficiency-blood stasis syndrome
|更新时间:2026-04-08
|
Clinical efficacy of herbal compress therapy with modified Taohong Siwu Decoction in patients with venous leg ulcers with qi deficiency-blood stasis syndrome
Beijing Journal of Traditional Chinese MedicineVol. 45, Issue 2, Pages: 155-159(2026)
XING Liang,KONG Hua,ZHANG Hua,et al.Clinical efficacy of herbal compress therapy with modified Taohong Siwu Decoction in patients with venous leg ulcers with qi deficiency-blood stasis syndrome[J]. Beijing Journal of Traditional Chinese Medicine,2026,45(02):155-159.
XING Liang,KONG Hua,ZHANG Hua,et al.Clinical efficacy of herbal compress therapy with modified Taohong Siwu Decoction in patients with venous leg ulcers with qi deficiency-blood stasis syndrome[J]. Beijing Journal of Traditional Chinese Medicine,2026,45(02):155-159. DOI: 10.16025/j.1674-1307.2026.02.002.
Clinical efficacy of herbal compress therapy with modified Taohong Siwu Decoction in patients with venous leg ulcers with qi deficiency-blood stasis syndrome
To observe the clinical efficacy of herbal compress therapy with modified
Taohong Siwu Decoction
combined with compression therapy in the treatment of venous leg ulcers (VLU) with
qi
deficiency-blood stasis syndrome.
Methods
2
A total of 72 patients with VLU who visited Wangjing Hospital of the China Academy of Chinese Medical Sciences between July 2024 and February 2025 were enrolled and randomly divided into an observation group and a control group (
n
=36 each) using a random number table method. The control group received compression therapy, routine wound dressing changes, and health education. Based on the treatment of the control group, the observation group additionally received herbal compress therapy with modified
Taohong Siwu Decoction
. The treatment duration was 4 weeks or until ulcer healing (complete epithelialization). The Chronic Venous Insufficiency Questionnaire (CIVIQ) score and Venous Clinical Severity Score (VCSS) were assessed before treatment and at weeks 2 and 4. Serum levels of growth factors [platelet-derived growth factor (PDGF), epidermal growth factor (EGF), and transforming growth factor-β (TGF-β)] and extracellular matrix factors [tissue inhibitor of metallop
roteinases-1 (TIMP-1) and matrix metalloproteinase-2 (MMP-2)] were measured before treatment and at week 4. Adverse events during treatment and the total effective rate after treatment were also recorded.
Results
2
The total effective rate in the observation group was 91.7%, which was higher than 80.6% in the control group (
P
=0.021). At weeks 2 and 4, CIVIQ scores in both groups were significantly increased compared with those before treatment (
P
<
0.05), while VCSS scores were significantly decreased (
P
<
0.05); both CIVIQ and VCSS scores in the observation group were superior to those in the control group (
P
<
0.05). After 4 weeks, serum levels of PDGF, EGF, and TGF-β in both groups were significantly increased compared with baseline (
P
<
0.05), and were higher in the observation group than in the control group (
P
<
0.05). Meanwhile, serum levels of TIMP-1 and MMP-2 in both groups were significantly decreased compared with baseline (
P
<
0.05), and were lower in the observation group than in the control group (
P
<
0.05). No serious adverse events occurred in either group.
Conclusion
2
Herbal compress therapy with modified
Taohong Siwu Decoction
demonstrates significant efficacy in the treatment of VLU, improving quality of life, regulating serum growth factors and extracellular matrix components, and exhibiting a high safety profile.
ALSHARIF AT , ALANAZI OI , ALQARNI RA , et al . The impact of nutritional condition and compression treatment on venous ulcer recovery: a systematic review [J ] . Cureus , 2024 , 16 ( 4 ): e57407 .
ALVAREZ OM , MARKOWITZ L , PARKER R , et al . faster healing and a lower rate of recurrence of venous ulcers treated with intermittent pneumatic compression: results of a randomized controlled trial [J ] . Eplasty , 2020 , 20 : e6 .
ZUBAIR M , AHMAD H . Role of growth factors and cytokines in diabetic foot ulcer healing: a detailed review [J ] . Rev Endocr Metab Disord , 2019 , 20 ( 2 ): 207 - 217 .
SANCHEZ MTC , ABELLO LMV , ORREGO A , et al . Use of intralesional and perilesional human recombinant epidermal growth factor (hregf) in the local treatment of venous ulcer - review article - expert recommendation [J ] . Vasc Health Risk Manag , 2023 , 19 : 595 - 603 .
YANG X , FAN W , HUANG R , et al . β-acetoxyisovaleryl alkannin (AAN-II) from Alkanna tinctoria promotes the healing of pressure-induced venous ulcers in a rabbit model through the activation of TGF-β/Smad3 signaling [J ] . Cell Mol Biol Lett , 2021 , 26 ( 1 ): 35 .
GRANDI V , BACCI S , CORSI A , et al . ALA-PDT exerts beneficial effects on chronic venous ulcers by inducing changes in inflammatory microenvironment, especially through increased TGF-beta release: a pilot clinical and translational study [J ] . Photodiagnosis Photodyn Ther , 2018 , 21 : 252 - 256 .
NEGARESH M , SAFARZADEH E , FOULADI N , et al . The evaluation of the MMP-2/TIMP-1 ratio in peptic ulcer and its association with refractory helicobacter pylori infection [J ] . BMC Gastroenterol , 2023 , 23 ( 1 ): 287 .
KOLANO P , BEDNARSKI IA , KRASKA-GACKA M , et al . Serum concentration of matrix metalloproteinases and angiogenic factors in patients with venous leg ulcers [J ] . Postepy Dermatol Alergol , 2021 , 38 ( 2 ): 230 - 234 .
Effects of intradermal needle embedding at the back-shu points combined with pulmonary rehabilitation training on lung function and quality of life in stable COPD patients
Multi⁃centered randomized controlled study of Chinese medicine integrated with chemotherapy for stage Ⅳ non⁃small cell lung cancer
Chinese Herbal Medicine Yiqi Jianpi Prescription combined with S-1 as first-line treatment for 41 aged cases of advanced gastric cancer
Effect of Qiting Lishui Prescription on clinical efficacy, quality of life and serum matrix metalloproteinases in patients with coronary heart disease and heart failure
Related Author
YANG Ping
XU Wei
WANG Fangyuan
Hong⁃sheng LIN
屠志涛
Qi⁃jin SHU
Hong⁃liang ZHANG
Shen⁃yu WANG
Related Institution
Rehabilitation Medicine Department, Hangzhou Third People's Hospital
北京市中医管理局
Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Internal Oncology Department of Integrated Traditional Chinese and Western Medicine,China-Japan Friendship Hospital
Department of Oncology,The First Affiliated Hospital of Guangzhou University of Chinese Medicine